Target intelligence / Profile preview

Cilium

Molecular classification
Other (organelle)
01

Overview

Cilia are microscopic hair-like organelles that extend from the surface of nearly all mammalian cells. They are composed of a microtubule-based structure called the axoneme and are surrounded by plasma membrane. There are two main types: Motile cilia have a "9+2" arrangement of microtubules and function primarily in movement—such as clearing mucus from the respiratory tract or moving eggs in the fallopian tubes. Non-motile (primary) cilia, with a "9+0" arrangement, typically serve as sensory organelles that coordinate various signaling pathways essential for development and tissue homeostasis. They act as cellular antennae for mechanosensation and chemosensation. Ciliary proteins are synthesized in the cytoplasm and transported into the growing or functioning cilium via intraflagellar transport (IFT), which is critical for both assembly and maintenance[2][8]. Defects in either motile or non-motile cilia can cause ciliopathies, an expanding group of genetic diseases affecting multiple organs including kidneys, eyes, brain, liver, and reproductive system[5]. Cilia themselves are not considered therapeutic targets like receptors or enzymes; rather they are complex organelles made up of many protein components—some individual proteins within them may be drug targets but "cilia" is not itself a molecular target suitable for structured drug discovery purposes. Because “cilia” refers to an entire class of cellular structures rather than a specific molecule/receptor/protein target—and because it is not itself directly targeted by drugs—the entry is marked as incorrect for use as a canonical therapeutic target name.[3][6]

Other names
Cilia (plural)Primary ciliumMotile ciliumNon-motile ciliumPrimary ciliaMotile cilia
02

Biological functions

Cell motilitySignal transductionMechanoreceptionSensory perceptionRegulation of cell cycle and development[3][5][7]
03

Disease associations

Ciliopathies (genetic disorders caused by defective cilia)Developmental disordersPolycystic kidney diseaseRetinal degeneration[5][8]
04

Safety considerations

Dysfunction leads to a range of genetic diseases known as ciliopathies[5]

Beyond the preview

Go deeper on Cilium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cilium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call